Tumor cell JAG1 promotes lymph node metastasis and predicts recurrence in lymph node positive breast cancer patients

Breast Cancer Research

First author: Gordon B.

Corresponding authors: Kitajewski J.

Injectable and viscoelastic click alginate hydrogels for spatio-temporal T cell administration in vivo

Materials Today Bio

First author: Berasain J.

Corresponding authors: Cipitria A.

Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial

Journal of Geriatric Oncology

First author: García-García J.

Corresponding authors: Basterrechea L.

Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer

The Journal of Clinical Investigation

First author: Palomeque JA.

Corresponding authors: Celià-Terrassa T.

Molecular characterisation of the residual disease after neoadjuvant endocrine therapy in ER+/HER2- breast cancer uncovers biomarkers of tumour response

Translational Oncology

First author: López-Velasco JI., Manzano S.

Corresponding authors: Caffarel MM., Urruticoechea A.

Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis

Science Advances

First author: Bakhshandeh S.

Corresponding authors: Cipitria A.

Cytokine-centered strategies to boost cancer immunotherapy

Molecular Oncology

First author: Manzano S.

Corresponding authors: Manzano S., Caffarel MM.

A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

Breast Cancer Research

First author: López-Velazco JI., Manzano S.

Corresponding authors: Caffarel MM., Urruticoechea A.

Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER(+) breast cancer

Science Translational Medicine

First author: Bacci M.

Corresponding authors: Morandi A.

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial

Nature Medicine

First author: Hiensch AE.

Corresponding authors: May AM.

Preventing alpelisib-related hyperglycaemia in HR+/HER2-/ PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

eClinicalMedicine

First author: Llombart-Cussac A.

Corresponding authors: Llombart-Cussac A.

Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study

Breast

First author: Cortés A.

Corresponding authors: Llombart-Cussac A.

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Nature Communications

First author: Tundidor I.

Corresponding authors: Pérez-Gomez, E.

Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature

Frontiers of Immunology

First author: Serna L., Azcoaga P.

Corresponding authors: S Braza, M.

New perspectives in cancer immunotherapy: targeting IL-6 cytokine family

Journal of Immunotherapy in Cancer

First author: Soler M. F., Abaurrea A., Azcoaga P.

Corresponding authors: Caffarel MM.

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

Journal of Clinical Investigation

First author: M Araujo A.

Corresponding authors: Caffarel MM.

Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature

Journal of Experimental & Clinical Cancer Research

First author: Caffarel MM.

Corresponding authors: S Braza, M.

The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression

International Journal of Molecular Science

First author: Abaurrea A.

Corresponding authors: Caffarel MM.